FUM.L Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 18:23):

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management...

Stats
Dzisiejszy wolumen	584 191
Średni wolumen	907 911
Kapitalizacja rynkowa	100.81M
EPS	£0 ( 2024-04-03 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-16.72
ATR14	£0.438 (1.31%)

Wolumen Korelacja

Długi: -0.15 (neutral)

Krótki: -0.07 (neutral)

Signal:(47.212) Neutral

Futura Medical PLC Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Futura Medical PLC Korelacja - Waluta/Towar

-0.63
( weak negative )

-0.70
( moderate negative )

-0.07
( neutral )

-0.67
( moderate negative )

0.47
( neutral )

0.16
( neutral )

Futura Medical PLC Finanse

Annual	2023
Przychody:	£3.10M
Zysk brutto:	£1.77M (57.22 %)
EPS:	£-0.0221

FY	2023
Przychody:	£3.10M
Zysk brutto:	£1.77M (57.22 %)
EPS:	£-0.0221

FY	2022
Przychody:	£0
Zysk brutto:	£-24 734.00 (0.00 %)
EPS:	£-0.0203

FY	2021
Przychody:	£0.00
Zysk brutto:	£0.00 (0.00 %)
EPS:	£-0.0183

Financial Reports:

No articles found.

Futura Medical PLC

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.